{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:32:44Z","timestamp":1779888764337,"version":"3.53.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science Project","award":["No. 2023KY197"],"award-info":[{"award-number":["No. 2023KY197"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Primary sclerosing cholangitis (PSC) is characterized by idiopathic intra- and extrahepatic bile duct inflammation and biliary fibrotic changes. Recurrent bile duct stones due to PLKR and UGT1A1 mutation is an extremely rare complications of PSC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 26-year-old male patient complains a history of recurrent yellow skin and urine for over a year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Following dynamic magnetic resonance cholangiopancreatography imaging, colonoscopic manifestation, liver biopsy and whole exome sequencing, the patient was finally diagnosed with PSC - ulcerative colitis with PLKR and UGT1A1 mutation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Following resolution of the obstruction, a long-term regimen of 1000\u2009mg\/d ursodeoxycholic acid in combination with 10\u2009mg\/d obeticholic acid to improve cholestasis, 8\u2009g\/d colestyramine to facilitate adsorption of excess bile acids and 1.2\u2009g\/d rifaximin to prevent biliary tract infection were prescribed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient\u2019s liver biochemical parameters have improved significantly. His condition is stable and has not undergone liver transplantation at this time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Close and dynamic detection of the patient\u2019s biliary ductal lesions play an important role in the diagnosis of PSC. In the event of relatively rare biliary complications, attention should be paid to the presence of gene mutation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041192","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:07:44Z","timestamp":1736258864000},"page":"e41192","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Primary sclerosing cholangitis with PLKR and UGT1A1 mutation manifested as recurrent bile duct stones: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-4999","authenticated-orcid":false,"given":"Yijun","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofei","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250909","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cld.2023.07.005","article-title":"Primary sclerosing cholangitis: epidemiology, diagnosis, and presentation.","volume":"28","author":"Sohal","year":"2024","journal-title":"Clin Liver Dis"},{"key":"R2-20250909","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.rcl.2022.05.007","article-title":"MR imaging in primary sclerosing cholangitis and other cholangitis.","volume":"60","author":"O\u2019Brien","year":"2022","journal-title":"Radiol Clin North Am"},{"key":"R3-20250909","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis.","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"R4-20250909","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"Van Munster","year":"2024","journal-title":"J Hepatol"},{"key":"R5-20250909","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features.","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"R6-20250909","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ibd\/izaa167","article-title":"Systematic review with meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease course of inflammatory bowel diseases.","volume":"27","author":"Attauabi","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R7-20250909","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age.","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"R8-20250909","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12072-020-10118-x","article-title":"Management of primary sclerosing cholangitis and its complications: an algorithmic approach.","volume":"15","author":"Prokopi\u010d","year":"2021","journal-title":"Hepatol Int"},{"key":"R9-20250909","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cld.2007.11.007","article-title":"Vanishing bile duct syndrome.","volume":"12","author":"Reau","year":"2008","journal-title":"Clin Liver Dis"},{"key":"R10-20250909","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment.","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"R11-20250909","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4253\/wjge.v15.i3.133","article-title":"Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: what factors to consider?","volume":"15","author":"Gravina","year":"2023","journal-title":"World J Gastrointest Endosc"},{"key":"R12-20250909","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R13-20250909","first-page":"1161","article-title":"Histopathological features predicting long-term clinical outcomes in patients with vanishing bile duct syndrome.","volume":"11","author":"Lv","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"R14-20250909","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13023-022-02597-y","article-title":"Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.","volume":"17","author":"Chen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R15-20250909","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1007\/s10620-022-07416-9","article-title":"ABCB4 mutations in adults cause a spectrum cholestatic disorder histologically distinct from other biliary disease.","volume":"67","author":"Sinha","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R16-20250909","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2021.02.003","article-title":"Six novel variants in the PKLR gene associated with pyruvate kinase deficiency in Argentinian patients.","volume":"91","author":"Milanesio","year":"2021","journal-title":"Clin Biochem"},{"key":"R17-20250909","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults.","volume":"136","author":"Grace","year":"2020","journal-title":"Blood"},{"key":"R18-20250909","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2147\/JBM.S353907","article-title":"Pyruvate kinase deficiency: current challenges and future prospects.","volume":"13","author":"Fattizzo","year":"2022","journal-title":"J Blood Med"},{"key":"R19-20250909","doi-asserted-by":"crossref","first-page":"114592","DOI":"10.1016\/j.bcp.2021.114592","article-title":"UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder.","volume":"190","author":"Liu","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R20-20250909","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2023.02.030","article-title":"Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a coming of age or an age-ist problem?","volume":"79","author":"Ricciuto","year":"2023","journal-title":"J Hepatol"},{"key":"R21-20250909","doi-asserted-by":"crossref","first-page":"1229271","DOI":"10.3389\/fgene.2023.1229271","article-title":"Case report: a rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of PKLR and UGT1A1 mutation.","volume":"14","author":"Wu","year":"2023","journal-title":"Front Genet"},{"key":"R22-20250909","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.32405","article-title":"Mechanisms and molecules: what are the treatment targets for primary biliary cholangitis?","volume":"76","author":"Mayo","year":"2022","journal-title":"Hepatology"},{"key":"R23-20250909","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis.","volume":"73","author":"Kowdley","year":"2020","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:01:45Z","timestamp":1757440905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041192","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}